Nonpharmacologic Pain Management in FQHC Primary Care Clinics
BeatPain Utah
1 other identifier
interventional
500
1 country
2
Brief Summary
The goal of this study is to improve pain management and reduce opioid reliance for patients with chronic back pain in Utah Federally-Qualified Health Centers (FQHCs). The study compares the effectiveness of nonpharmacologic pain treatments using telehealth to overcome access barriers. We will use automated EHR reminders for electronic referral to teleconsult services. Our project tests adaptive treatments and uses a hybrid type I design - focused on effectiveness outcomes while gathering implementation data to inform future efforts to scale effective strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 low-back-pain
Started Nov 2021
Longer than P75 for phase_3 low-back-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2021
CompletedFirst Posted
Study publicly available on registry
June 11, 2021
CompletedStudy Start
First participant enrolled
November 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 21, 2026
August 7, 2024
August 1, 2024
4.6 years
June 1, 2021
August 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PEG-3
The PEG-3 measure includes 3 items evaluating 1) pain severity, and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores with higher scores indicating greater pain impact
12 weeks
Secondary Outcomes (7)
Physical Function
baseline, 12-, 26- and 52-weeks
Sleep Disturbance
baseline, 12-, 26- and 52-weeks
Pain Catastrophizing
baseline, 12-, 26- and 52-weeks
Pain Self-Efficacy
baseline, 12-, 26- and 52-weeks
Global Impression of Change
baseline, 12-, 26- and 52-weeks
- +2 more secondary outcomes
Study Arms (2)
Brief Pain Teleconsult
EXPERIMENTALParticipants randomized to Brief Pain Teleconsult will receive the brief teleconsult intervention in Phase 1 (1-12 weeks) Responder status to the Phase 1 treatment will be examined at the 12 week assessment. Participants determined to be non-responders will receive the Telehealth Physical Therapy intervention. Responders receive no additional treatment.
Brief Pain Teleconsult plus Telehealth Physical Therapy
EXPERIMENTALParticipants randomized to Brief Pain Teleconsult plus Telehealth Physical Therapy will receive the brief teleconsult intervention in Phase 1 followed by the 10-week physical therapy intervention. No additional treatment is provided after the 12 week assessment.
Interventions
The Brief Pain Teleconsult intervention includes 2 sessions provided by a licensed physical therapist over about 1 week. The sessions focus on pain education from a biopsychosocial perspective that is designed to address negative pain appraisals and catastrophizing thoughts, providing advice to be active and engage in exercise and physical activity, and reassurance that activity is beneficial and safe.
The Telehealth Physical Therapy intervention involves weekly telehealth sessions provided over 10 weeks. Telehealth Physical Therapy is provided by a licensed physical therapist. Key components of the intervention include reinforcing biopsychosocial education messages and developing an exercise and physical activity program using cognitive behavioral principles such as goal setting and positive reinforcement. Pain coping strategies including mindful breathing and progressive relaxation techniques will be included.
Eligibility Criteria
You may qualify if:
- Able to communicate in English or Spanish
- Age between 18-80
- Visit with an FQHC provider (in-person or via telehealth) in past 90 days
- Back pain has been an ongoing problem for at least the past 3 months, and has been a problem on at least half the days in the past 6 months
- Access to resources necessary to receive telehealth sessions (phone or 2-way video)
You may not qualify if:
- Currently pregnant
- Currently involved in active substance use disorder treatment (other than peer support groups, AA, etc.)
- History of spine surgery in past 6 months
- Has a condition restricting participation in physical activity (i.e., unable to ambulate independently (with or without assistive device) for at least 5 minutes.
- Reason for back pain is a fracture or non-musculoskeletal condition (i.e., spinal tumor, inflammatory disorder, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Duke Universitycollaborator
Study Sites (2)
Association of Utah Community Health
Salt Lake City, Utah, 84106, United States
The University of Utah Healthcare System
Salt Lake City, Utah, 84108, United States
Related Publications (4)
Fritz JM, Del Fiol G, Gibson B, Wetter DW, Solis V, Bennett E, Thackeray A, Goode A, Lundberg K, Romero A, Ford I, Stevens L, Siaperas T, Morales J, Yack M, Greene T. BeatPain Utah: study protocol for a pragmatic randomised trial examining telehealth strategies to provide non-pharmacologic pain care for persons with chronic low back pain receiving care in federally qualified health centers. BMJ Open. 2022 Nov 9;12(11):e067732. doi: 10.1136/bmjopen-2022-067732.
PMID: 36351735BACKGROUNDFritz JM, Gibson B, Wetter DW, Del Fiol G, Solis V, Ford I, Lundberg K, Thackeray A. Use of implementation mapping in the planning of a hybrid type 1 pragmatic clinical trial: the BeatPain Utah study. Implement Sci Commun. 2024 Jan 5;5(1):3. doi: 10.1186/s43058-023-00542-z.
PMID: 38183154BACKGROUNDFritz JM, Ford I, George SZ, Vinci de Vanegas L, Cope T, Burke CA, Goode AP. Telehealth delivery of physical therapist-led interventions for persons with chronic low back pain in underserved communities: lessons from pragmatic clinical trials. Front Pain Res (Lausanne). 2024 Apr 19;5:1324096. doi: 10.3389/fpain.2024.1324096. eCollection 2024.
PMID: 38706872BACKGROUNDFritz JM, Gibson B, Wetter DW, Fiol GD, Solis VH, Ford I, Lundberg K, Thackeray A. Use of implementation mapping in the planning of a hybrid type 1 pragmatic clinical trial: the BeatPain Utah study. Res Sq [Preprint]. 2023 Sep 11:rs.3.rs-3267087. doi: 10.21203/rs.3.rs-3267087/v1.
PMID: 37790359DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The study is outcome assessor and investigator blinded. Blinding will only be broken in emergency situations for reasons of participant safety such as a serious adverse event. If blinding is broken, either intentionally or unintentionally, the reason will be fully documented and entered on an electronic case report form. Every effort will be made to discuss the decision to break blinding with the Data Safety Monitoring Board in advance.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor
Study Record Dates
First Submitted
June 1, 2021
First Posted
June 11, 2021
Study Start
November 4, 2021
Primary Completion (Estimated)
June 21, 2026
Study Completion (Estimated)
June 21, 2026
Last Updated
August 7, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Following completion of the data collection
IPD will be shared through the HEAL initiative at NIH